Replies to post #423050 on Amarin Corp Plc (AMRN)

[Whalatane]

Capt ...from the Science Direct link ...Vascepa with prior MI patients ( about 3600 in R-IT )

. Sudden cardiac death and cardiac arrest were also significantly reduced by 40% and 56%, respectively.

These are huge numbers
Why isn't some one ( Kaiser etc ) trying to independently verify this degree of risk reduction ( or at least some degree of this risk reduction )
Its a narrow population ...prior MI's on Vascepa and you're only looking at sudden cardiac death and cardiac arrest .
There has to be RWE ( real world evidence ) on that .

Kiwi